Aspartyl alpha-((diphenylphosphinyl)oxy)methyl ketones as novel inhibitors of interleukin-1 beta converting enzyme. Utility of the diphenylphosphinic acid leaving group for the inhibition of cysteine proteases
- J Med Chem. 1995 Jan 20;38(2):220-2. doi: 10.1021/jm00002a002.
Affiliations
- 1. Department of Medicinal Chemistry, Sterling Winthrop Pharmaceuticals Research Division, Collegeville, Pennsylvania 19426.
PMID: 7830263
DOI: 10.1021/jm00002a002
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: Amino Acid DerivativesResearch Areas: Cancer